Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of Citrasate®, citric acid
dialysate enables the reduction of the heparin N (anticoagulant) dose in patients undergoing
hemodialysis.